311 related articles for article (PubMed ID: 18288990)
1. DNA damage repair and response proteins as targets for cancer therapy.
Lieberman HB
Curr Med Chem; 2008; 15(4):360-7. PubMed ID: 18288990
[TBL] [Abstract][Full Text] [Related]
2. The DNA damage response: implications for tumor responses to radiation and chemotherapy.
Goldstein M; Kastan MB
Annu Rev Med; 2015; 66():129-43. PubMed ID: 25423595
[TBL] [Abstract][Full Text] [Related]
3. Targeting BER enzymes in cancer therapy.
Visnes T; Grube M; Hanna BMF; Benitez-Buelga C; Cázares-Körner A; Helleday T
DNA Repair (Amst); 2018 Nov; 71():118-126. PubMed ID: 30228084
[TBL] [Abstract][Full Text] [Related]
4. Molecular inhibitors of DNA repair: searching for the ultimate tumor killing weapon.
Nikitaki Z; Michalopoulos I; Georgakilas AG
Future Med Chem; 2015 Aug; 7(12):1543-58. PubMed ID: 26306465
[TBL] [Abstract][Full Text] [Related]
5. Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment.
Rozpędek W; Pytel D; Nowak-Zduńczyk A; Lewko D; Wojtczak R; Diehl JA; Majsterek I
Curr Med Chem; 2019; 26(8):1425-1445. PubMed ID: 29345572
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathways: exploiting tumor-specific molecular defects in DNA repair pathways for precision cancer therapy.
Dietlein F; Reinhardt HC
Clin Cancer Res; 2014 Dec; 20(23):5882-7. PubMed ID: 25451105
[TBL] [Abstract][Full Text] [Related]
7. Mismatch repair and response to DNA-damaging antitumour therapies.
Bignami M; Casorelli I; Karran P
Eur J Cancer; 2003 Oct; 39(15):2142-9. PubMed ID: 14522371
[TBL] [Abstract][Full Text] [Related]
8. Repair and translesion DNA polymerases as anticancer drug targets.
Maga G; Hübscher U
Anticancer Agents Med Chem; 2008 May; 8(4):431-47. PubMed ID: 18473728
[TBL] [Abstract][Full Text] [Related]
9. DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy.
Nadin SB; Vargas-Roig LM; Drago G; Ibarra J; Ciocca DR
Cancer Lett; 2006 Jul; 239(1):84-97. PubMed ID: 16143448
[TBL] [Abstract][Full Text] [Related]
10. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
Kinsella TJ
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
[TBL] [Abstract][Full Text] [Related]
11. DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy.
de Almeida LC; Calil FA; Machado-Neto JA; Costa-Lotufo LV
Cancer Genet; 2021 Apr; 252-253():6-24. PubMed ID: 33340831
[TBL] [Abstract][Full Text] [Related]
12. DNA repair pathways and their implication in cancer treatment.
Pallis AG; Karamouzis MV
Cancer Metastasis Rev; 2010 Dec; 29(4):677-85. PubMed ID: 20821251
[TBL] [Abstract][Full Text] [Related]
13. DNA repair protein: endo-exonuclease as a new frontier in cancer therapy.
Chow TY; Choudhury SA
Future Oncol; 2005 Apr; 1(2):265-71. PubMed ID: 16555998
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target Approach.
Lodovichi S; Cervelli T; Pellicioli A; Galli A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932697
[TBL] [Abstract][Full Text] [Related]
15. Targeting DNA damage and repair: embracing the pharmacological era for successful cancer therapy.
Aziz K; Nowsheen S; Pantelias G; Iliakis G; Gorgoulis VG; Georgakilas AG
Pharmacol Ther; 2012 Mar; 133(3):334-50. PubMed ID: 22197993
[TBL] [Abstract][Full Text] [Related]
16. The interacting pathways for prevention and repair of oxidative DNA damage.
Slupphaug G; Kavli B; Krokan HE
Mutat Res; 2003 Oct; 531(1-2):231-51. PubMed ID: 14637258
[TBL] [Abstract][Full Text] [Related]
17. A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage.
Meyers M; Hwang A; Wagner MW; Bruening AJ; Veigl ML; Sedwick WD; Boothman DA
Oncogene; 2003 Oct; 22(47):7376-88. PubMed ID: 14576845
[TBL] [Abstract][Full Text] [Related]
18. DNA repair proteins as molecular targets for cancer therapeutics.
Kelley MR; Fishel ML
Anticancer Agents Med Chem; 2008 May; 8(4):417-25. PubMed ID: 18473726
[TBL] [Abstract][Full Text] [Related]
19. [Impairment of DNA damage response and cancer].
Rancoule C; Vallard A; Guy JB; Espenel S; Sauvaigo S; Rodriguez-Lafrasse C; Magné N
Bull Cancer; 2017 Nov; 104(11):962-970. PubMed ID: 29132683
[TBL] [Abstract][Full Text] [Related]
20. Targeting the microRNA-regulating DNA damage/repair pathways in cancer.
Bottai G; Pasculli B; Calin GA; Santarpia L
Expert Opin Biol Ther; 2014 Nov; 14(11):1667-83. PubMed ID: 25190496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
